Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alterome Therapeutics

Request full access

A biopharmaceutical company developing alteration-specific targeted therapies

San Diego, United StatesFounded 2021Biotech & Life Sciences

About Alterome Therapeutics

Alterome is a startup that operates in the healthcare sector, specifically in the field of oncology. The company's primary objective is to transform the lives of cancer patients by discovering precise therapies that inspire hope. They aim to accelerate the development of targeted therapies using a structure-guided drug discovery approach. This approach allows them to design alteration-specific therapies that precisely target high-value, validated oncogenic drivers, providing treatment options for patients who have very few alternatives.

Alterome serves a critical market segment - cancer patients who are in desperate need of effective treatment options. The company's business model revolves around the research, development, and commercialization of targeted therapies for cancer. They generate revenue through the successful development and sale of these therapies.

The company prides itself on its team of dedicated scientists and business professionals. Unlike traditional top-down companies, Alterome operates on a co-elevation model, where everyone's opinions, knowledge, and experience are valued. This collaborative approach, coupled with their commitment to integrity, empathy, and humility, is what they believe will enable them to achieve their mission.

In summary, Alterome is a patient-focused company that is dedicated to discovering precise, targeted therapies for cancer. They operate in a collaborative, respectful environment where everyone's contributions are valued, and they believe that this approach will enable them to succeed in their mission.

Source: Dealroom company data

At a glance

Status
Operational
Employees
40
Open positions
None listed
Dealroom signal
68.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Drug Development, Biotech and Pharma, Small Molecules, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Apr 2024 $132M $528M Goldman Sachs · Invus · OrbiMed · Blue Owl Capital ↗
SERIES AOther financing Nov 2022 $35M $320M Boxer Capital · OrbiMed · Vida Ventures · Nextech Invest ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Alterome Therapeutics website traffic

Latest recorded traffic for Alterome Therapeutics is 2.4K monthly website visits, down 40% over the last three months. Alterome Therapeutics's team declined 7% over the past year.

Latest monthly visits2.4K 3-month web change-40% 1-year team growth-7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Alterome Therapeutics in the San Diego ecosystem

Live from Dealroom

The Alterome Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

  • OrbiMed
  • Vida Ventures
  • Boxer Capital
  • Nextech Invest
  • Colt Ventures
  • Goldman Sachs
  • Invus
  • Blue Owl Capital
  • Canaan
  • Driehaus Capital Management
  • Digitalis Ventures
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Alterome Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.